Genome AnnouncGenome AnnouncgagaGAGenome Announcements2169-8287American Society for Microbiology1752 N St., N.W., Washington, DC267443684706339genomeA01234-1510.1128/genomeA.01234-15ProkaryotesDraft Genomes for Eight Burkholderia mallei Isolates from TurkeyGenome AnnouncementDaligault et al.DaligaultH. E.ahttp://orcid.org/0000-0002-3972-9208JohnsonS. L.aDavenportK. W.aMinogueT. D.bBishop-LillyK. A.cdBroomallS. M.eBruceD. C.aCoyneS. R.bFreyK. G.cdGibbonsH. S.eJaissleJ.bKorolevaG. I.bLadnerJ. T.bLoC.-C.aMunkC.aWolcottM. J.bPalaciosG. F.bReddenC. L.cdRosenzweigC. N.eScholzM. B.afChainP. S.aLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USAUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USANaval Medical Research Center (NMRC), Frederick, Fort Detrick, Maryland, USAHenry M. Jackson Foundation, Bethesda, Maryland, USAUnited States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USAMichigan State University (MSU), East Lansing, Michigan, USAAddress correspondence to S. L. Johnson, shannonj@lanl.gov.712016Jan-Feb201641e01234-1515920159112015Copyright © 2016 Daligault et al.2016Daligault et al.This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.

Burkholderia mallei, the etiologic agent of glanders, is a Gram-negative, nonmotile, facultative intracellular pathogen. Although glanders has been eradicated from many parts of the world, the threat of B. mallei being used as a weapon is very real. Here we present draft genome assemblies of 8 Burkholderia mallei strains that were isolated in Turkey.

DTRA, the funders, had no role in study design, data collection and interpretation, or the decision to submit the work for publication.cover-dateJanuary/February 2016
GENOME ANNOUNCEMENT

Burkholderia mallei is a host-adapted bacterium that is not known to persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East, and Central and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. mallei and there is concern regarding its use as a biothreat agent (1). Although human epidemics have not been recorded, isolated outbreaks in human populations and the deliberate use of B. mallei as a biological weapon have been documented (2, 3). In fact, B. mallei was one of the first biological warfare agents used in the 20th century, specifically during World War I (4). B. mallei has been considered a potential threat since the 1940s because of its high infectivity, degree of incapacitation, and agent availability. Here we present the draft genome sequences of 8 B. mallei strains that were collected in Turkey.

The B. mallei Turkey strains were isolated from either human or horse glanders cases (Table 1) by the Etlik Veterinary Control and Research Institute (Ankara, Turkey). We do not know the original isolation date for the horse isolates. The human isolates were obtained in the 1960s. The isolates were passaged in guinea pigs every 2 to 3 years to maintain pathogenicity and were re-isolated from the spleen and liver. The last passages of these isolates were in January 1984. The National Veterinary Services Laboratories (Ames, Iowa) obtained these cell lines in 1984 and froze the isolates.

Listing of Burkholderia mallei isolate genomes released to NCBI

StrainAccession no.SRASourceGenome size (bp)No. of contigs (scaffolds)% G+CNo. of CDSsaNo. of tRNAsNo. of rRNAs
Turkey1JNUY00000000SRP060201Horse5,455,153244 (2)68.605,050544
Turkey2JNUZ00000000SRP060209Horse5,475,037302 (15)68.605,135515
Turkey4JPGF00000000SRP060248Human5,456,585297 (5)68.505,124514
Turkey5JPGI00000000SRP060264Human5,421,535239 (2)68.505,095504
Turkey6JPGH00000000SRP060249Horse5,446,114229 (3)68.505,045555
Turkey7JPGO00000000SRP060250Horse5,655,761141 (3)68.505,058525
Turkey8JPGJ00000000SRP060262Horse5,575,84912 (2)68.504,894537
Turkey10JNOV00000000SRP060210Horse5,425,647100 (2)68.604,800525

CDS, coding sequence.

High-quality genomic DNA was extracted from purified isolates using QIAgen Genome Tip-500. Specifically, 100-mL bacterial cultures were grown to stationary phase and nucleic acid extracted as per manufacturer’s recommendations. Draft genome assemblies included two data sets (specific data types and coverages are listed in the NCBI records). Turkey 10 strain had Illumina short- (ca. 300-bp) and long-insert (generally >8 kb) paired data; all the other strains had Illumina short-insert paired data and Roche 454 long-insert paired data. Short- and long-insert paired data were assembled together in both Newbler and Velvet, and computationally shredded into 1.5 kbp overlapping shreds. All data were additionally assembled together in Allpaths (5). Consensus sequences from Allpaths were computationally shredded into 10 kbp overlapping pieces. All shreds were integrated using Phrap. Possible misassemblies were corrected and repeat regions verified using in-house scripts and manual editing in Consed (6, 7). Each genome assembly was annotated using an Ergatis-based (8) workflow with minor manual curation. Burkholderia mallei Turkey 3 and 9 were also sequenced, however, produced lower quality assemblies; these genomes can be found in NCBI under accession numbers JOLB00000000 and JNLU00000000, respectively.

Genome assemblies ranged from 12 to 302 contigs and 2 to 15 scaffolds (Table 1). As expected for the genus, % G+C was high, averaging 68.5%.

Nucleotide sequence accession numbers.

Accession numbers for all 8 genomes are listed in Table 1.

Citation Daligault HE, Johnson SL, Davenport KW, Minogue TD, Bishop-Lilly KA, Broomall SM, Bruce DC, Coyne SR, Frey KG, Gibbons HS, Jaissle J, Koroleva GI, Ladner JT, Lo C-C, Munk C, Wolcott MJ, Palacios GF, Redden CL, Rosenzweig CN, Scholz MB, Chain PS. 2016. Draft genomes for eight Burkholderia mallei isolates from Turkey. Genome Announc 4(1):e01234-15. doi:10.1128/genomeA.01234-15.

ACKNOWLEDGMENTS

Funding for this effort was provided by U.S. Defense Threat Reduction Agency. This manuscript was approved by LANL for unlimited release (LA-UR-15-26484).

We are grateful to Linda K. Schlater (National Veterinary Services Laboratories) for providing strain provenances.

REFERENCESJelesijevicT, ZimmermanSM, HarveySB, MeadDG, ShafferTL, EstesDM, MichelF, QuinnFD, HoganRJ, LafontaineER 2015 Use of the common marmoset to study Burkholderia mallei infection. PLoS One 10:e0124181. doi:10.1371/journal.pone.0124181.25860021WhitlockGC, EstesDM, TorresAG 2007 Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277:115122. doi:10.1111/j.1574-6968.2007.00949.x.18031330ChristopherGW, CieslakTJ, PavlinJA, EitzenEMJr. 1997 Biological warfare. A historical perspective. JAMA 278:412417. doi:10.1001/jama.278.5.412.9244333WheelisM 1998 First shots fired in biological warfare. Nature 395:213. doi:10.1038/26089.9751039ButlerJ, MacCallumI, KleberM, ShlyakhterIA, BelmonteMK, LanderES, NusbaumC, JaffeDB 2008 ALLPATHS: de novo assembly of whole-genome shotgun microreads. Genome Res 18:810820. doi:10.1101/gr.7337908.18340039EwingB, GreenP 1998 Base-calling of automated sequencer traces using Phred. II. Error probabilities. Genome Res 8:186194. doi:10.1101/gr.8.3.186.9521922GordonD, AbajianC, GreenP 1998 Consed: A graphical tool for sequence finishing. Genome Res 8:195202. doi:10.1101/gr.8.3.195.9521923HemmerichC, BuechleinA, PodichetiR, RevannaKV, DongQ 2010 An Ergatis-based prokaryotic genome annotation web server. BioInformatics 26:11221124. doi:10.1093/bioinformatics/btq090.20194626